SOURCE: MediXall Group, Inc.

MediXall Group, Inc.

August 29, 2017 08:00 ET

MediXall Group, Inc. and SafeRide Health Announce Partnership to Reduce Medical Appointment No-Shows

FORT LAUDERDALE, FL--(Marketwired - Aug 29, 2017) - MediXall Group Inc., (OTCQB: MDXL), a technology and innovation-driven organization structured to bring effective change to the U.S. healthcare industry is pleased to announce that it has partnered SafeRide Health to promote its flagship on-demand medical transportation platform to the MediXaid Provider Network.

MediXall's wholly-owned subsidiary, MediXaid is completing development of a new generation healthcare marketplace platform to address the growing need of self-pay and high deductible consumers for greater transparency and price competition in their healthcare costs. The MediXaid platform provides a B2C capability that brings together into a single cloud-based, patent-pending virtual marketplace the consumers of healthcare products and services with providers that compete on price, location and schedule for requested products and services.

SafeRide Health is a technology company whose mission is to connect patients to care. Studies repeatedly indicate that lack of reliable transportation is one of the most significant barriers to care. As the market moves towards value based arrangements, treatment adherence is critical (ER visits cost $160Bn annually). Accordingly, SafeRide Health helps the nation's leading health providers simplify medical transport to improve patient outcomes.

The SafeRide Platform delivers:

  • Lyft plus medically qualified transport in on integrated platform
  • On-demand and scheduled medical transport to solve the problem of "no-shows"
  • Tools to engage the patient (increasing treatment adherence), and
  • Analytics to identify and triage "at risk" patients

SafeRide's light intuitive SaaS platform requires no up-front costs and is ready to use immediately.

Why it matters to Care providers:

Roughly 25-45% of appointments are cancelled or changed "day of". This creates significant cost and operational complexity for physicians and providers of care. SafeRide connects care providers to appropriate medical fleets to manage no-shows and transportation for high risk or high need patients. Further, SafeRide allows patients to self-fund transportation to their appointments.

With the SafeRide platform, provider groups can now realize smoother daily operations. SafeRide enables reliable patient in-flows, reduced cancellations, and safe, simple, transport home.

Noel J. Guillama, Chairman of MediXall Group, commented, "Currently, medical care providers are facing material challenges that go well beyond attracting new patients; a league of issues being driven by consumers, payers and state and federal government. As part of our MediXall business model, we are selecting revolutionary products and services that will help MediXaid Provider Network members increase their net margins and keep more of their revenue, as well as assist in reducing their business operations burden. Today, we are introducing new products that can help medical care providers simplify medical transport, streamline care coordination and improve patient outcomes. We are setting a new standard for the provider/patient relationship through a revolutionary patient portal that facilitates faster and more convenient physician-patient interaction."

Robbins Schrader, CEO of SafeRide Health said, "We're thrilled to partner with the MediXall team. We see material opportunity to improve the patient experience, patient outcome and simplify practice operations."

About MediXall Group, Inc.
MediXall Group is a technology and innovation-driven organization purposefully designed and structured to bring effective change to the U.S. healthcare industry that is actively trading on the OTCQB under the symbol "MDXL." The Company believes its revolutionary approach will help drive much needed change that it envisions is needed in the current healthcare system. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. By approaching the healthcare ecosystem as a whole, MediXall creates, invests and incubates companies that embody its mission statement. MediXall's first acquisition was MediXaid®, a developing cloud-based software platform that promises to revolutionize the way people purchase healthcare goods and services.

About MediXaid
The first product MediXall is developing is the MediXaid Platform, which is on schedule for a 4th quarter launch. The MediXaid Platform is a new generation healthcare marketplace platform to address the growing need of self-pay and high deductible consumers for greater transparency and price competition in their healthcare costs. With MediXaid.com, patient/clients find price transparency and the ability to make informed choices based on price, location and schedule for requested medical products and services. In this era of rapidly increasing deductibles and healthcare costs, the cloud-based MediXaid platform is designed to be transformational and disruptive to traditional methods of medical care and provisioning of medical services to the consumer.

About SafeRide Health
SafeRide Health is a digital health platform that improves access to care by delivering medically qualified transport and Lyft. SafeRide Health simplifies health system operations, improves patient outcomes, and reduces cost for some of the U.S.'s leading healthcare systems. SafeRide's network fulfills over 45,000 rides a week across Los Angeles, Seattle, Portland, St. Louis, the broader Midwest, and the greater New York area. Learn more at www.saferidehealth.com. Contact: team@saferidehealth.com

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. Specifically, the Company's ability to raise additional capital, execute its business plan and strategy, sustain or increase gross margins, achieve profitability and build shareholder value are forward looking statements. A more extensive listing of risks and factors that may affect the Company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the Company with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

  • Contact
    Steve Bryant
    VP Director Relations
    MediXall Group, Inc.
    Phone: (954) 908-3481
    Email: sbryant@medixall.com